Clinical Trials List
Protocol NumberCCD070101
2009-07-01 - 2010-06-30
Phase III
Study ended1
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
124 participants
-
Global
0 participants
